Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quality Improvement | 2 | 2020 | 699 | 0.510 |
Why?
|
| Designer Drugs | 1 | 2015 | 4 | 0.480 |
Why?
|
| Patient Safety | 1 | 2020 | 443 | 0.460 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 123 | 0.440 |
Why?
|
| Curriculum | 1 | 2020 | 776 | 0.440 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 150 | 0.440 |
Why?
|
| Smad4 Protein | 1 | 2011 | 58 | 0.340 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 492 | 0.340 |
Why?
|
| Mitral Valve | 1 | 2011 | 252 | 0.300 |
Why?
|
| Aorta | 1 | 2011 | 534 | 0.270 |
Why?
|
| Fentanyl | 1 | 2024 | 54 | 0.220 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2026 | 209 | 0.210 |
Why?
|
| Analgesics | 1 | 2024 | 122 | 0.210 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2026 | 200 | 0.200 |
Why?
|
| Pain Management | 1 | 2024 | 198 | 0.190 |
Why?
|
| Sepsis | 1 | 2026 | 502 | 0.170 |
Why?
|
| Ketamine | 1 | 2024 | 226 | 0.170 |
Why?
|
| DNA Repair Enzymes | 1 | 2021 | 39 | 0.170 |
Why?
|
| DNA Modification Methylases | 1 | 2021 | 47 | 0.170 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 419 | 0.160 |
Why?
|
| Formative Feedback | 1 | 2020 | 32 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 468 | 0.160 |
Why?
|
| Problem-Based Learning | 1 | 2020 | 78 | 0.150 |
Why?
|
| Peer Group | 1 | 2020 | 122 | 0.150 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2023 | 293 | 0.150 |
Why?
|
| Program Evaluation | 1 | 2020 | 440 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 486 | 0.140 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 157 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2026 | 1202 | 0.130 |
Why?
|
| Professionalism | 1 | 2018 | 45 | 0.130 |
Why?
|
| Mutation | 1 | 2011 | 6144 | 0.130 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 152 | 0.120 |
Why?
|
| Radiology | 1 | 2018 | 124 | 0.120 |
Why?
|
| Glioma | 1 | 2021 | 495 | 0.120 |
Why?
|
| Emergency Medicine | 1 | 2018 | 171 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2020 | 1441 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 993 | 0.120 |
Why?
|
| Students, Medical | 1 | 2020 | 340 | 0.120 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 203 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 4008 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1616 | 0.090 |
Why?
|
| Menstruation | 1 | 2012 | 26 | 0.090 |
Why?
|
| Menorrhagia | 1 | 2012 | 81 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 1278 | 0.090 |
Why?
|
| Intestinal Polyposis | 1 | 2011 | 17 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2020 | 6443 | 0.090 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2011 | 79 | 0.080 |
Why?
|
| Humans | 10 | 2026 | 130931 | 0.070 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2007 | 37 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 824 | 0.070 |
Why?
|
| Photoreceptor Cells | 1 | 2007 | 91 | 0.070 |
Why?
|
| Pedigree | 1 | 2011 | 1703 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 249 | 0.060 |
Why?
|
| Organ Dysfunction Scores | 1 | 2026 | 52 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 884 | 0.060 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2024 | 58 | 0.060 |
Why?
|
| Female | 7 | 2026 | 70755 | 0.050 |
Why?
|
| Propensity Score | 1 | 2024 | 261 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2024 | 352 | 0.050 |
Why?
|
| Male | 6 | 2026 | 64823 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2026 | 1069 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2023 | 233 | 0.040 |
Why?
|
| Middle Aged | 3 | 2026 | 28735 | 0.040 |
Why?
|
| Sex Factors | 1 | 2023 | 1344 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1068 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 1217 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2018 | 94 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2026 | 17485 | 0.030 |
Why?
|
| Program Development | 1 | 2018 | 184 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3799 | 0.030 |
Why?
|
| Aged | 2 | 2026 | 21134 | 0.030 |
Why?
|
| Adult | 3 | 2024 | 31541 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2021 | 1082 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2026 | 2558 | 0.030 |
Why?
|
| Child | 2 | 2012 | 26098 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2013 | 36 | 0.030 |
Why?
|
| Beverages | 1 | 2013 | 100 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4930 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6862 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 1102 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2012 | 501 | 0.020 |
Why?
|
| Rod Opsins | 1 | 2007 | 17 | 0.020 |
Why?
|
| Electroretinography | 1 | 2007 | 107 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 315 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2007 | 127 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 359 | 0.020 |
Why?
|
| Models, Animal | 1 | 2007 | 459 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 331 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3327 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1614 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2007 | 1021 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 1852 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 3850 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 18410 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 34278 | 0.000 |
Why?
|